Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review
Xinyang Fu,Zhiqiang Lin,Sumei Chen,Limian Hong,Xueping Yu,Shuifa Wu
DOI: https://doi.org/10.2147/IDR.S319013
2021-07-02
Infection and Drug Resistance
Abstract:Xinyang Fu, 1, &ast Zhiqiang Lin, 1, &ast Sumei Chen, 2 Limian Hong, 1 Xueping Yu, 2 Shuifa Wu 1 1 Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, People's Republic of China; 2 Department of Infectious Disease, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shuifa Wu Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, No. 250 East Street, Licheng District, Quanzhou, Fujian, 362000, People's Republic of China Email Xueping Yu Department of Infectious Disease, Quanzhou First Hospital Affiliated to Fujian Medical University, No. 250 East Street, Licheng District, Quanzhou, Fujian, 362000, People's Republic of China Email The pharmacokinetic/pharmacodynamic (PK/PD) parameter for evaluating the efficacy of vancomycin is now recommended to target an AUC/MIC (area under the curve, AUC; minimum inhibitory concentration, MIC) ratio of 400 to 600, and trough concentration should not be used as a substitute. We report a case of intracranial infection caused by methicillin-resistant Staphylococcus epidermidis (MRSE), which was sensitive to vancomycin (MIC=2μg/mL) and linezolid (MIC=4μg/mL). The trough concentration of vancomycin in serum was 18.3 μg/mL, and the vancomycin concentration in CSF was 5.0 μg/mL, all within normal range. However, the AUC/MIC ratio was calculated to be 125 mg·h·L − 1 , unable to reach target AUC/MIC. Vancomycin was replaced with linezolid after 36 days of treatment due to poor outcome, and the patient was eventually cured. Further, 23 cases of intracranial methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-resistant coagulase-negative Staphylococcus (MRCoNS) infections were reported, of which 1 case with MRSA had a vancomycin MIC of 1 μg/mL, while the remaining 22 cases had vancomycin MICs > 1 μg/mL. The linezolid-containing regimen was used after drug susceptibility results or if the initial treatment failed, leading to recovery in 19 patients, microbial clearance in 3 patients, and treatment failure in 1 case. In conclusion, vancomycin dosing should be based on AUC-guided dosing and monitoring. When the vancomycin MIC of MRSA/MRCoNS is > 1 μg/mL, the target AUC/MIC may not be achieved. In such cases, linezolid can effectively be considered as a good alternative to vancomycin. Keywords: AUC/MIC, trough concentration, intracranial infection, vancomycin, linezolid In hospitalized patients, the integrity of the blood–brain barrier (BBB) can be disrupted by several invasive procedures, such as craniotomy, the placement ventricular catheters, lumbar puncture, and intrathecal infusions. In such situations, specific microorganisms can invade the central nervous system (CNS) through BBB, leading to health care-associated meningitis or ventriculitis (HCAMV). 1 The majority of HCAMV cases are caused by Gram-positive cocci, particularly coagulase-negative staphylococci . Infectious Diseases Society of America (IDSA) guidelines recommend vancomycin combined with anti- Pseudomonas β-lactam drugs as an empirical treatment for HCAMV. However, when the vancomycin MIC of MRSA or MRCoNS is greater than 1 μg/mL, linezolid, daptomycin, or sulfamethoxazole should be considered instead. 2 Herein, we report a patient with intracranial Staphylococcus epidermidis infection who recovered after vancomycin was replaced by linezolid due to poor outcome. To better investigate the sensitivity of vancomycin and the feasibility of linezolid-containing regimen, we further reviewed the available reported intracranial infections cases caused by MRSA or MRCoNS, and analyzed the efficacy of linezolid, which may hopefully help clinicians perform optimal antibiotic therapy for this kind of infection. A 67-year-old male patient was admitted to our hospital on March 20, 2020 with a complaint of sudden disturbance of consciousness. An emergency head CT scan showed 1. left basal ganglia haemorrhage with intraventricular extension, 2. bilateral lacunar infarctions at basal ganglia and senile brain degeneration, 3. mild bilateral inflammation of ethmoid sinuses. An emergency lung CT scan showed chronic bronchitis-emphysema, pulmonary bullae, and mild chronic inflammation of both lungs. Physical examination at admission showed a body temperature of 36.7°C, a pulse of 100 bpm, a respiratory rate of 21 breaths per minute, and a blood pressure of 156/92 mm Hg. The patient was in a light coma and showed no response to instruct -Abstract Truncated-
pharmacology & pharmacy,infectious diseases